Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus

Immunobiology

Volumn 220, Issue 8, 2015, Pages 976-984

  Guzman Flores, Juan M ^a   Cortez Espinosa, Nancy ^a   Cortés Garcia, Juan D ^a   Vargas Morales, Juan M ^a   Cataño Cañizalez, Yolanda G ^a   Rodríguez Rivera, Jaime G ^b   Portales Perez, Diana P ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b HOSPITAL CENTRAL DR IGNACIO MORONES PRIETO   (Mexico)

Author keywords

Apoptosis; Diabetes type 2; Inflammation; Obesity; Regulatory T cells

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE DERIVATIVE; CD39 ANTIGEN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; LIPOCORTIN 5; TRIACYLGLYCEROL; 2-(4-(2-CARBOXYETHYL)PHENETHYLAMINO)-5'-N-ETHYLCARBOXAMIDOADENOSINE; APYRASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; NT5E PROTEIN, HUMAN; PHENETHYLAMINE DERIVATIVE; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BODY MASS; CD8+ T LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; METABOLIC REGULATION; MICROENVIRONMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; ANALOGS AND DERIVATIVES; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTE; METABOLISM;

5'-NUCLEOTIDASE; ADENOSINE; ADULT; ANTIGENS, CD; APOPTOSIS; APYRASE; BODY MASS INDEX; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HUMANS; INFLAMMATION; LYMPHOCYTE SUBSETS; LYMPHOCYTES; OBESITY; PHENETHYLAMINES; RECEPTOR, ADENOSINE A2A; TRIAZINES; TRIAZOLES;

EID: 85001740643     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.02.007     Document Type: Article

References (43)

1. Antonioli L., Pacher P., Vizi E.S., Hasko G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 2013, 19:355-367. 10.1016/j.molmed.2013.03.005.
2. Apasov S., Chen J.F., Smith P., Sitkovsky M. A(2A) receptor dependent and A(2A) receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency. Blood 2000, 95:3859-3867. http://www.bloodjournal.org/content/95/12/3859.long?sso-checked=true.
3. Apasov S.G., Chen J.F., Smith P.T., Schwarzschild M.A., Fink J.S., Sitkovsky M.V. Study of A(2A) adenosine receptor gene deficient mice reveals that adenosine analogue CGS 21680 possesses no A(2A) receptor-unrelated lymphotoxicity. Br. J. Pharmacol. 2000, 131:43-50. 10.1038/sj.bjp.0703532.
4. Barbieri D., Abbracchio M.P., Salvioli S., Monti D., Cossarizza A., Ceruti S., Brambilla R., Cattabeni F., Jacobson K.A., Franceschi C. Apoptosis by 2-chloro-2'-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells. Neurochem. Int. 1998, 32:493-504. 10.1016/S0197-0186(97)00129-0.
5. Borsellino G., Kleinewietfeld M., Di Mitri D., Sternjak A., Diamantini A., Giometto R., Hopner S., Centonze D., Bernardi G., Dell'Acqua M.L., Rossini P.M., Battistini L., Rotzschke O., Falk K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007, 110:1225-1232. 10.1182/blood-2006-12-064527.
6. Brint E., O'Callaghan G., Houston A. Life in the Fas lane: differential outcomes of Fas signaling. Cell. Mol. Life Sci. 2013, 70:4085-4099. 10.1007/s00018-013-1327-z.
7. Burghoff S., Flogel U., Bongardt S., Burkart V., Sell H., Tucci S., Ikels K., Eberhard D., Kern M., Kloting N., Eckel J., Schrader J. Deletion of CD73 promotes dyslipidemia and intramyocellular lipid accumulation in muscle of mice. Arch. Physiol. Biochem. 2013, 119:39-51. 10.3109/13813455.2012.755547.
8. Butler J.J., Mader J.S., Watson C.L., Zhang H., Blay J., Hoskin D.W. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways. J. Cell. Biochem. 2003, 89:975-991. 10.1002/jcb.10562.
9. Clayton A., Al-Taei S., Webber J., Mason M.D., Tabi Z. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J. Immunol. 2011, 187:676-683. 10.4049/jimmunol.1003884.
10. Chiacchio T., Casetti R., Butera O., Vanini V., Carrara S., Girardi E., Di Mitri D., Battistini L., Martini F., Borsellino G., Goletti D. Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis. Clin. Exp. Immunol. 2009, 156:463-470. 10.1111/j.1365-2249.2009.03908.x.
11. Deaglio S., Dwyer K.M., Gao W., Friedman D., Usheva A., Erat A., Chen J.F., Enjyoji K., Linden J., Oukka M., Kuchroo V.K., Strom T.B., Robson S.C. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007, 204:1257-1265. 10.1084/jem.20062512.
12. Dwyer K.M., Hanidziar D., Putheti P., Hill P.A., Pommey S., McRae J.L., Winterhalter A., Doherty G., Deaglio S., Koulmanda M., Gao W., Robson S.C., Strom T.B. Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am. J. Transplant. 2010, 10:2410-2420. 10.1111/j.1600-6143.2010.03291.x.
13. Enjyoji K., Kotani K., Thukral C., Blumel B., Sun X., Wu Y., Imai M., Friedman D., Csizmadia E., Bleibel W., Kahn B.B., Robson S.C. Deletion of cd39/entpd1 results in hepatic insulin resistance. Diabetes 2008, 57:2311-2320. 10.2337/db07-1265.
14. Espinoza-Jimenez A., Peon A.N., Terrazas L.I. Alternatively activated macrophages in types 1 and 2 diabetes. Mediat. Inflamm. 2012, 2012:815953. 10.1155/2012/815953.
15. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A.B., Benoist C., Shoelson S., Mathis D. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009, 15:930-939. 10.1038/nm.2002.
16. Garcia-Hernandez M.H., Portales-Cervantes L., Cortez-Espinosa N., Vargas-Morales J.M., Fritche Salazar J.F., Rivera-Lopez E., Rodriguez-Rivera J.G., Quezada-Calvillo R., Portales-Perez D.P. Expression and function of P2X(7) receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters. Cell. Immunol. 2011, 269:135-143. 10.1016/j.cellimm.2011.03.022.
17. Gessi S., Varani K., Merighi S., Ongini E., Borea P.A. A(2A) adenosine receptors in human peripheral blood cells. Br. J. Pharmacol. 2000, 129:2-11. 10.1038/sj.bjp.0703045.
18. Guzman-Flores J.M., Lopez-Briones S. Cells of innate and adaptive immunity in type 2 diabetes and obesity. Gac. Med. Mex. 2012, 148:381-389. http://www.anmm.org.mx/GMM/2012/n4/GMM_148_2012_4_381-389.pdf.
19. Guzman-Flores J.M., Portales-Perez D.P. Mechanisms of suppression of regulatory T-cells (Treg). Gac. Med. Mex. 2013, 149:630-638. http://www.anmm.org.mx/GMM/2013/n6/GMM_149_2013_6_630-638.pdf.
20. Heuts D.P., Weissenborn M.J., Olkhov R.V., Shaw A.M., Gummadova J., Levy C., Scrutton N.S. Crystal structure of a soluble form of human CD73 with ecto-5'-nucleotidase activity. ChemBioChem 2012, 13:2384-2391. 10.1002/cbic.201200426.
21. Himer L., Csoka B., Selmeczy Z., Koscso B., Pocza T., Pacher P., Nemeth Z.H., Deitch E.A., Vizi E.S., Cronstein B.N., Hasko G. Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death. FASEB J. 2010, 24:2631-2640. 10.1096/fj.10-155192.
22. Hoskin D.W., Mader J.S., Furlong S.J., Conrad D.M., Blay J. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Int. J. Oncol. 2008, 32:527-535. 10.3892/ijo.32.3.527.
23. Jacobson K.A., Hoffmann C., Cattabeni F., Abbracchio M.P. Adenosine-induced cell death: evidence for receptor-mediated signalling. Apoptosis 1999, 4:197-211. 10.1023/A:1009666707307.
24. Jagannathan-Bogdan M., McDonnell M.E., Shin H., Rehman Q., Hasturk H., Apovian C.M., Nikolajczyk B.S. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J. Immunol. 2011, 186:1162-1172. 10.4049/jimmunol.1002615.
25. Kobie J.J., Shah P.R., Yang L., Rebhahn J.A., Fowell D.J., Mosmann T.R. T regulatory and primed uncommitted CD4T cells express CD73, which suppresses effector CD4T cells by converting 5'-adenosine monophosphate to adenosine. J. Immunol. 2006, 177:6780-6786. 10.4049/jimmunol.177.10.6780.
26. Linden J., Cekic C. Regulation of lymphocyte function by adenosine. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2097-2103. 10.1161/ATVBAHA.111.226837.
27. Mandapathil M., Hilldorfer B., Szczepanski M.J., Czystowska M., Szajnik M., Ren J., Lang S., Jackson E.K., Gorelik E., Whiteside T.L. Generation and accumulation of immunosuppressive adenosine by human CD4+ CD25 high FOXP3+ regulatory T cells. J. Biol. Chem. 2010, 285:7176-7186. 10.1074/jbc.M109.047423.
28. Otton R., Soriano F.G., Verlengia R., Curi R. Diabetes induces apoptosis in lymphocytes. J. Endocrinol. 2004, 182:145-156. 10.1677/joe.0.1820145.
29. Panther E., Corinti S., Idzko M., Herouy Y., Napp M., la Sala A., Girolomoni G., Norgauer J. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 2003, 101:3985-3990. 10.1182/blood-2002-07-2113.
30. Pulte E.D., Broekman M.J., Olson K.E., Drosopoulos J.H., Kizer J.R., Islam N., Marcus A.J. CD39/NTPDase-1 activity and expression in normal leukocytes. Thromb. Res. 2007, 121:309-317. 10.1016/j.thromres.2007.04.008.
31. Ramakers B.P., Wever K.E., Kox M., van den Broek P.H., Mbuyi F., Rongen G., Masereeuw R., van der Hoeven J.G., Smits P., Riksen N.P., Pickkers P. How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo. Crit. Care Med. 2012, 40:2609-2616. 10.1097/CCM.0b013e318259205b.
32. Regateiro F.S., Cobbold S.P., Waldmann H. CD73 and adenosine generation in the creation of regulatory microenvironments. Clin. Exp. Immunol. 2013, 171:1-7. 10.1111/j.1365-2249.2012.04623.x.
33. Saze Z., Schuler P.J., Hong C.S., Cheng D., Jackson E.K., Whiteside T.L. Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood 2013, 122:9-18. 10.1182/blood-2013-02-482406.
34. Scalia R. The microcirculation in adipose tissue inflammation. Rev. Endocr. Metab. Disord. 2013, 14:69-76. 10.1007/s11154-013-9236-x.
35. Schmetterer K.G., Neunkirchner A., Pickl W.F. Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. FASEB J. 2012, 26:2253-2276. 10.1096/fj.11-193672.
36. Shu C.J., Benoist C., Mathis D. The immune system's involvement in obesity-driven type 2 diabetes. Semin. Immunol. 2012, 24:436-442. 10.1016/j.smim.2012.12.001.
37. Smyth L.A., Ratnasothy K., Tsang J.Y., Boardman D., Warley A., Lechler R., Lombardi G. CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function. Eur. J. Immunol. 2013, 43:2430-2440. 10.1002/eji.201242909.
38. Sun J., Zhang Y., Yang M., Xie Q., Li Z., Dong Z., Yang Y., Deng B., Feng A., Hu W., Mao H., Qu X. Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A(2). Cell. Mol. Immunol. 2010, 7:77-82. 10.1038/cmi.2009.105.
39. Wagner N.M., Brandhorst G., Czepluch F., Lankeit M., Eberle C., Herzberg S., Faustin V., Riggert J., Oellerich M., Hasenfuss G., Konstantinides S., Schafer K. Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring). 2013, 21:461-468. 10.1002/oby.20087.
40. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., Dorfman R., Wang Y., Zielenski J., Mastronardi F., Maezawa Y., Drucker D.J., Engleman E., Winer D., Dosch H.M. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 2009, 15:921-929. 10.1038/nm.2001.
41. Wojcik M., Zieleniak A., Mac-Marcjanek K., Wozniak L.A., Cypryk K. The elevated gene expression level of the A2B adenosine receptor is associated with hyperglycemia in women with gestational diabetes mellitus. Diabetes Metab. Res. Rev. 2014, 30:42-53. 10.1002/dmrr.2446.
42. Xu H., Chen Y., Li Y., Xia F., Han B., Zhang H., Zhai H., Wu H., Lu Y. Mitochondrial apoptosis of lymphocyte is induced in type 2 diabetes. Chin. Med. J. (Engl.) 2014, 127:213-217. 10.3760/cma.j.issn.0366-6999.20131906.
43. Zeng C., Shi X., Zhang B., Liu H., Zhang L., Ding W., Zhao Y. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J. Mol. Med. (Berl.) 2012, 90:175-186. 10.1007/s00109-011-0816-5.